TW200716613A - Tubulin inhibitor and process for its preparation - Google Patents

Tubulin inhibitor and process for its preparation

Info

Publication number
TW200716613A
TW200716613A TW095120855A TW95120855A TW200716613A TW 200716613 A TW200716613 A TW 200716613A TW 095120855 A TW095120855 A TW 095120855A TW 95120855 A TW95120855 A TW 95120855A TW 200716613 A TW200716613 A TW 200716613A
Authority
TW
Taiwan
Prior art keywords
preparation
tubulin inhibitor
hemifumarate
tubulin
pyrazin
Prior art date
Application number
TW095120855A
Other languages
English (en)
Chinese (zh)
Inventor
David Michael Blum
yan-zhong Wu
Jean Schmid
Timothy John Doyle
Jay Thomas Afragola
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37074929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200716613(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200716613A publication Critical patent/TW200716613A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW095120855A 2005-06-13 2006-06-12 Tubulin inhibitor and process for its preparation TW200716613A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69001605P 2005-06-13 2005-06-13
US80278106P 2006-05-24 2006-05-24

Publications (1)

Publication Number Publication Date
TW200716613A true TW200716613A (en) 2007-05-01

Family

ID=37074929

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095120855A TW200716613A (en) 2005-06-13 2006-06-12 Tubulin inhibitor and process for its preparation

Country Status (12)

Country Link
EP (1) EP1891052A1 (fr)
JP (1) JP2008543838A (fr)
AR (1) AR054392A1 (fr)
AU (1) AU2006259663A1 (fr)
BR (1) BRPI0612145A2 (fr)
CA (1) CA2610416A1 (fr)
GT (1) GT200600257A (fr)
MX (1) MX2007015718A (fr)
PE (1) PE20070114A1 (fr)
SV (1) SV2007002573A (fr)
TW (1) TW200716613A (fr)
WO (1) WO2006138180A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2581207T3 (es) 2009-11-12 2016-09-02 Tube Pharmaceuticals Gmbh Inhibidores de la tubulina
EP2903436B1 (fr) * 2012-09-19 2019-07-17 The Trustees Of The University Of Pennsylvania Composés hétérocycliques et leur utilisation pour le traitement de tauopathies neurodégénératives
WO2017181974A1 (fr) * 2016-04-20 2017-10-26 苏州苏领生物医药有限公司 Composé hétérocyclique à cinq chaînons, procédé de préparation correspondant, composition pharmaceutique et utilisation
WO2019169111A1 (fr) 2018-03-02 2019-09-06 The Trustees Of The University Of Pennsylvania Composés de [1,2,4]triazolo[1,5-a]pyrimidine et utilisation de ces derniers dans la stabilisation de microtubules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003207A (es) * 2003-09-24 2006-06-23 Wyeth Corp 5-arilpirimidinas como agentes anti-cancer.
CN100519559C (zh) * 2003-09-24 2009-07-29 惠氏控股公司 作为抗癌剂的6-[(经取代的)苯基]三唑并嘧啶

Also Published As

Publication number Publication date
AU2006259663A1 (en) 2006-12-28
SV2007002573A (es) 2007-01-03
PE20070114A1 (es) 2007-02-03
BRPI0612145A2 (pt) 2010-10-19
EP1891052A1 (fr) 2008-02-27
JP2008543838A (ja) 2008-12-04
GT200600257A (es) 2007-02-14
AR054392A1 (es) 2007-06-20
MX2007015718A (es) 2008-02-21
CA2610416A1 (fr) 2006-12-28
WO2006138180A1 (fr) 2006-12-28

Similar Documents

Publication Publication Date Title
GB2446084A (en) Synthesis of four color 3-o-allyl modified photocleavable fluorescent nucleotides and related methods
AU306008S (en) Duffel
EP1989335A4 (fr) Traitement de surface d' articles metalliques dans un four atmospherique
EP1620256A4 (fr) Surfaces de nanofibres destinees a etre utilisees dans des applications de surface active amelioree
GB0521944D0 (en) Method of treating gas
HK1095749A1 (en) Novel use of peptide compounds for in production of pharmacenticals for treating central neuropathic pain
EP1904661A4 (fr) Traitement de surface duplex d objets métalliques
TW200716613A (en) Tubulin inhibitor and process for its preparation
HK1100011A1 (en) Component of musical instrument, musical instrument and production method of the same
TWI370481B (en) Plasma chamber having multiple rf source frequencies
ZA200604680B (en) Process for the preparation of tubulin inhibitors
SG158860A1 (en) Processes for the preparation of aminoethoxybenzyl alcohols
UA96269C2 (uk) Інгібітори цистеїнпротеази та їх терапевтичне застосування
EP1848550A4 (fr) Traitement de mordançage de surfaces de substrats et de chambres
IL183597A0 (en) Manufacture process of n-substituted salicylamides
ZA200703826B (en) Manufacture process of N-substituted salicylamides
PT2258847T (pt) Outras novas formas de moléculas de arn de interferência
SG121993A1 (en) Process for influencing the properties of combustion residue
IL184519A0 (en) Protease inhibitor precursor synthesis
CA113787S (en) Lever
TW200621698A (en) Synthesis of idarubicin aglycone
GB0424939D0 (en) Process for the production of gaskets
TW200516066A (en) Improvement of ceramic process technology
CA114525S (en) Belt
RS20050543A (en) Process and intermediates for the preparation of olanzapine